Accueil/Actions/RNXT

RNXT

USD

RenovoRx Inc. Common Stock

$1.020-0.050 (-4.673%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.070

Haut

$1.100

Bas

$1.010

Volume

0.22M

Fondamentaux de l'Entreprise

Capitalisation Boursière

37.4M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.56M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.75Actuel $1.020Haut $1.69

Actualités Connexes

4 nov. 2025 · 13:30

GlobeNewswire

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

27 oct. 2025 · 12:30

GlobeNewswire

RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET

MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing